Table: Towa Pharmaceutical -2020/21 group results

TOWA PHARMACEUTICAL

14/05/2021 07:00

May 14 (Reuters)- 
          Towa Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            154.90          110.38         165.00        80.55    
                 (+40.3 pct)     (+5.0 pct)     (+6.5 pct)    (+7.9 pct) 
  Operating         19.92           16.14          17.40         8.41    
                 (+23.4 pct)     (+1.1 pct)     (-12.7 pct)   (-5.6 pct) 
  Recurring         18.68           20.99          17.60         8.49    
                 (-11.0 pct)     (+11.3 pct)    (-5.8 pct)    (-4.1 pct) 
  Net
  Net               13.96           14.50          12.00         5.80    
                 (-3.8 pct)      (+7.6 pct)     (-14.0 pct)   (-9.1 pct) 
  EPS            283.62 yen      294.74 yen     243.83 yen    117.85 yen 
  EPS Diluted    271.93 yen      272.62 yen                              
  Ann Div         44.00 yen       44.00 yen      51.00 yen               
  -Q2 Div         22.00 yen       22.00 yen      27.00 yen               
  -Q4 Div         22.00 yen       22.00 yen      24.00 yen               
  
  NOTE - Towa Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T